George Sellers
Stock Analyst at Stephens & Co.
(1.04)
# 3,859
Out of 5,046 analysts
43
Total ratings
27.27%
Success rate
-7.09%
Average return
Main Sectors:
Stocks Rated by George Sellers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ESTA Establishment Labs Holdings | Reiterates: Overweight | $68 | $47.95 | +41.81% | 7 | Aug 7, 2024 | |
| TFX Teleflex | Maintains: Overweight | $275 → $290 | $124.47 | +132.99% | 9 | Aug 2, 2024 | |
| VCEL Vericel | Maintains: Overweight | $56 → $58 | $35.06 | +65.43% | 2 | Aug 2, 2024 | |
| TMDX TransMedics Group | Maintains: Overweight | $151 → $178 | $131.54 | +35.32% | 2 | Aug 2, 2024 | |
| ANIK Anika Therapeutics | Reiterates: Equal-Weight | $24 | $9.75 | +146.15% | 6 | May 29, 2024 | |
| ENOV Enovis | Initiates: Overweight | $72 | $31.24 | +130.47% | 1 | Feb 13, 2024 | |
| APYX Apyx Medical | Maintains: Overweight | $8 → $5 | $3.03 | +65.02% | 2 | Nov 10, 2023 | |
| TMCI Treace Medical Concepts | Reiterates: Equal-Weight | $25 | $6.39 | +291.24% | 4 | Sep 12, 2023 | |
| STAA STAAR Surgical Company | Reiterates: Overweight | $57 | $25.87 | +120.33% | 6 | Aug 14, 2023 | |
| GKOS Glaukos | Reiterates: Overweight | $71 | $88.07 | -19.38% | 4 | May 8, 2023 |
Establishment Labs Holdings
Aug 7, 2024
Reiterates: Overweight
Price Target: $68
Current: $47.95
Upside: +41.81%
Teleflex
Aug 2, 2024
Maintains: Overweight
Price Target: $275 → $290
Current: $124.47
Upside: +132.99%
Vericel
Aug 2, 2024
Maintains: Overweight
Price Target: $56 → $58
Current: $35.06
Upside: +65.43%
TransMedics Group
Aug 2, 2024
Maintains: Overweight
Price Target: $151 → $178
Current: $131.54
Upside: +35.32%
Anika Therapeutics
May 29, 2024
Reiterates: Equal-Weight
Price Target: $24
Current: $9.75
Upside: +146.15%
Enovis
Feb 13, 2024
Initiates: Overweight
Price Target: $72
Current: $31.24
Upside: +130.47%
Apyx Medical
Nov 10, 2023
Maintains: Overweight
Price Target: $8 → $5
Current: $3.03
Upside: +65.02%
Treace Medical Concepts
Sep 12, 2023
Reiterates: Equal-Weight
Price Target: $25
Current: $6.39
Upside: +291.24%
STAAR Surgical Company
Aug 14, 2023
Reiterates: Overweight
Price Target: $57
Current: $25.87
Upside: +120.33%
Glaukos
May 8, 2023
Reiterates: Overweight
Price Target: $71
Current: $88.07
Upside: -19.38%